NCT04275466

Brief Summary

The infected pancreatic necrosis (IPN) should be treated by debridement and drainage. In recent years, the results of clinical research show that minimally invasive debridement such as video-assisted (laparoscope, nephroscope, endoscopy, etc.) and total laparoscopic debridement can significantly improve the prognosis of IPN patients. After a long period of clinical practice, laparoscope-assisted debridement was selected as the main surgical method in our center. In many large-scale clinical studies, patients after surgery underwent necrotic cavity lavage (such as small omental sac lavage, retroperitoneal space lavage, peripancreatic lavage, etc.), but its necessity and clinical significance were not clearly stated in the guidelines. At present, the clinical research mainly focuses on the improvement of minimally invasive debridement, and less on the necessity of lavage. In the past, necrotic cavity lavage was performed in IPN patients, but long-term clinical observation showed that lavage may lead to spread of infection and increase the incidence of lower extremity venous thrombosis which is not accorded with ERAS(Enhanced Recovery After Surgery). Therefore, since 2012, our center has stopped necrotic cavity lavage for IPN patients after debridement. We retrospectively analyzed the therapeutic effect from February 2014 to August 2017 and found that even without necrotic cavity lavage, better therapeutic effect could be achieved. Meanwhile it can simplify the operation process and avoid infection spread. This treatment method provides a new idea. However, it is a retrospective study not a randomized controlled trials(RCT) which is low effectiveness of proof. Therefore, we design this RCT to verify the necessity of necrotic cavity lavage after laparoscope-assisted debridement for patients with infected pancreatic necrosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 19, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

June 12, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2021

Completed
Last Updated

June 18, 2020

Status Verified

February 1, 2020

Enrollment Period

1 year

First QC Date

February 12, 2020

Last Update Submit

June 16, 2020

Conditions

Keywords

acute pancreatitisinfected pancreatic necrosislaparoscope-assisted debridementnecrotic cavity lavage

Outcome Measures

Primary Outcomes (1)

  • sum rate of mortality and major complications

    number of deaths and major complications (new organ failure or intraperitoneal hemorrhage/gastrointestinal fistula requiring surgical treatment)/total enrollment

    1 year

Secondary Outcomes (10)

  • physiological parameter

    through study completion, an average of 2 months

  • physiological parameter

    through study completion, an average of 2 months

  • assay index

    through study completion, an average of 2 months

  • assay index

    through study completion, an average of 2 months

  • assay index

    through study completion, an average of 2 months

  • +5 more secondary outcomes

Study Arms (2)

necrotic cavity lavage

EXPERIMENTAL

This arm was performed necrotic cavity lavage after debridement

Procedure: necrotic cavity lavage

non-necrotic cavity lavage

NO INTERVENTION

This arm was not performed necrotic cavity lavage after debridement

Interventions

1. At least two 30- to 36-Fr drainage tubes will be placed into each necrotic cavity. One of these drainage tubes will be used as the lavage tube; the other tube is designed for drainage. 2. Lavage will begin on the first day after debridement, and the relevant indices will be evaluated every 7 days to decide whether to continue the lavage. 3. 1200 mL of normal saline will be lavaged into each necrotic cavity every day at a speed of 200 mL/h for 3 hours each time and for a total of two times. The start times of lavage will be 08:00 and 20:00. 4. The lavage and drainage volumes of the first hour and second hour of each lavage session will be calculated. The lavage of the next hour will be stopped if the lavage volume minus the drainage volume is \>100 mL. 5. Lavage will be suspended if abdominal pain and distention occur, the maximum body temperature is \>38.5ºC, or the abdominal pressure is ≥15 mmHg during the lavage procedure.

necrotic cavity lavage

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of IPN
  • onset time of \>4 weeks
  • performance of LAD for IPN
  • provision of written informed consent

You may not qualify if:

  • the highest temperature in 24 hours of ≥38.5ºC
  • new organ failure occurring within 24 hours after the operation
  • digestive tract fistula, biliary tract or digestive tract obstruction, or bleeding occurring within 24 hours after the operation
  • abdominal pressure of ≥10 mmHg within 24 hours after the operation
  • traumatic pancreatitis or a pancreatic fistula-related infection after the pancreatic operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xuanwu hospital Capital Medical University

Beijing, Beijing Municipality, 100053, China

RECRUITING

MeSH Terms

Conditions

Pancreatitis, Acute NecrotizingPancreatitis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Study Officials

  • Fei Li, MD

    Xuanwu Hospital, Beijing

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2020

First Posted

February 19, 2020

Study Start

June 12, 2020

Primary Completion

June 12, 2021

Study Completion

October 12, 2021

Last Updated

June 18, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations